FISCHER, MB., I. HAUBER, H. EGGENBAUER, Vojtěch THON, E. VOGEL, E. SCHAFFER, J. LOKAJ, J. LITZMAN, HM. WOLF and JW. MANNHALTER. A DEFECT IN THE EARLY PHASE OF T-CELL RECEPTOR-MEDIATED T-CELL ACTIVATION IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY. BLOOD. 1994, vol. 84, No 12, p. 4234-4241, 7 pp. ISSN 0006-4971.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A DEFECT IN THE EARLY PHASE OF T-CELL RECEPTOR-MEDIATED T-CELL ACTIVATION IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY
Name in Czech Porucha časné fáze TCR zprostředkované T buněčné aktivace u pacientů s běžnou variabilní imunodeficiencí
Authors FISCHER, MB. (40 Austria), I. HAUBER (276 Germany), H. EGGENBAUER (40 Austria), Vojtěch THON (203 Czech Republic, guarantor), E. VOGEL (40 Austria), E. SCHAFFER (40 Austria), J. LOKAJ (203 Czech Republic), J. LITZMAN (203 Czech Republic), HM. WOLF (40 Austria) and JW. MANNHALTER (40 Austria).
Edition BLOOD, 1994, 0006-4971.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher Russian Federation
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/94:00035804
Organization unit Faculty of Medicine
UT WoS A1994PX14600028
Keywords (in Czech) CVID; TCR; T lymfocyt
Keywords in English HUMAN B CELLS; PROLIFERATIVE RESPONSES; INTERFERON GAMMA; GENE EXPRESSION; INTERLEUKIN 2; HYPOGAMMAGLOBULINEMIA; IL 2; ANTIGEN; DIFFERENTIATION; ABNORMALITIES
Tags abnormalities, ANTIGEN, differentiation, GENE EXPRESSION, HUMAN B CELLS, hypogammaglobulinemia, IL 2, interferon gamma, interleukin 2, PROLIFERATIVE RESPONSES
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Vojtěch Thon, Ph.D., učo 2483. Changed: 26/6/2009 00:32.
Abstract
Common variable immunodeficiency (CVID) is characterized by an impairment of specific antibody production and a decrease in all or selected Ig isotypes. Abnormalities at the level of the B cells, T cells, and antigen-presenting cells have been described. In the present study, we have focused our attention on T-cell activation in CVID. T cells from 15 of 24 patients failed to respond to recall antigens leg, tetanus toxoid, Escherichia coli), Of these 15 patients, 11 were studied in detail and showed significantly decreased T-cell proliferative responses and/or decreased interleukin-2 and interferon-gamma production on T-cell receptor-mediated stimulation with recall antigens and superantigens (staphylococcal enterotoxins [SEI); however, T-cell response to mitogens (anti-CD3 monoclonal antibody, phytohemagglutinin) was normal. The defect in interleukin-2 and interferon-gamma release on tetanus toroid stimulation could also be documented in purified CD4 T cells of the patients and was present in patients with high and normal CD8 counts alike. Furthermore, patients' T cells failed to mount a significant elevation in free intracellular calcium (Ca++ flux) in response to superantigen, whereas the response to phorbol myristate acetate and ionomycin, bypassing receptor-mediated signaling, was unimpaired. These results indicate a defect in the early phase of T-cell activation after triggering of the T-cell receptor in a significant subgroup of CVID patients.
Abstract (in Czech)
Porucha časné fáze TCR zprostředkované T buněčné aktivace u pacientů s běžnou variabilní imunodeficiencí.
PrintDisplayed: 5/5/2024 14:13